Terms ending in 2037
Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,590,128 | 6,7,8,9-Tetrahydro-5H-pyrido[2,3-d]azepine Dopamine D3 Ligands In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,390,623 | 6,7,8,9-Tetrahydro-5H-pyrido[2,3-d]azepine Dopamine D3 Ligands In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 10,221,242 | Antibodies Specific for Epidermal Growth Factor Receptor Variant III and Their Uses In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,259,876 | Chimeric Antigen Receptors Targeting Epidermal Growth Factor Receptor Variant III In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,869,924 | PD-L1 Antagonist Combination Treatments In force · High confidence | Merck Patent GmbH | In force | High confidence | |
| US 10,723,727 | Tubulysin Analogs and Methods for Their Preparation In force · High confidence | Pfizer Healthcare Ireland | In force | High confidence | |
| US 10,323,042 | 6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,738,063 | 6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 10,144,738 | Pyrazolo[1,5-a]pyrazin-4-yl Derivatives In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 10,822,341 | Pyrazolo[1,5-a]pyrazin-4-yl Derivatives In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| 48 more term ends in 2037 · Pro | |||||
10 of 58 patents shown. Soonest term end first, then patent number.
Pro members see all 58.
55 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.